Herold Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $401K | Buy |
10,433
+634
| +6% | +$24.3K | 0.08% | 206 |
|
|
2025
Q1 | $380K | Sell |
9,799
-360
| -4% | -$13.9K | 0.08% | 198 |
|
|
2024
Q4 | $344K | Sell |
10,159
-139
| -1% | -$4.7K | 0.07% | 208 |
|
|
2024
Q3 | $421K | Sell |
10,298
-395
| -4% | -$16.2K | 0.09% | 200 |
|
|
2024
Q2 | $412K | Sell |
10,693
-234
| -2% | -$9.01K | 0.1% | 196 |
|
|
2024
Q1 | $469K | Buy |
10,927
+246
| +2% | +$10.5K | 0.11% | 185 |
|
|
2023
Q4 | $396K | Buy |
10,681
+511
| +5% | +$18.9K | 0.11% | 182 |
|
|
2023
Q3 | $369K | Sell |
10,170
-9
| -0.1% | -$326 | 0.11% | 183 |
|
|
2023
Q2 | $363K | Sell |
10,179
-372
| -4% | -$13.3K | 0.11% | 181 |
|
|
2023
Q1 | $375K | Sell |
10,551
-4,091
| -28% | -$146K | 0.13% | 161 |
|
|
2022
Q4 | $515K | Sell |
14,642
-11,916
| -45% | -$419K | 0.22% | 110 |
|
|
2022
Q3 | $781K | Sell |
26,558
-1,030
| -4% | -$30.3K | 0.38% | 87 |
|
|
2022
Q2 | $1.5M | Buy |
27,588
+1,226
| +5% | +$66.7K | 0.67% | 45 |
|
|
2022
Q1 | $1.44M | Buy |
26,362
+10,515
| +66% | +$573K | 0.51% | 64 |
|
|
2021
Q4 | $873K | Buy |
15,847
+2,083
| +15% | +$115K | 0.34% | 95 |
|
|
2021
Q3 | $657K | Buy |
+13,764
| New | +$657K | 0.26% | 104 |
|